WelGENE, Inc. is a gene-based biopharmaceutical company that is dedicated to the development of the next generation of antisense molecules(our propriety 4th and 5th generation antisense technologies) and functional genomics. The company is focusing on the discovery of disease-related genes through our proprietary, antisense platform technologies. In addition, we are developing nontoxic, stable, antisense therapeutics to treat important medical conditions such as tissue fibrosis, cancer, obesity, and inflammatory diseases.